Hydroxylapatite
Molecular Structure:
MDL:
--MFCD00010904
Molecular Formula:
HCa5O13P3;3Ca3(PO4)2·Ca(OH)2
Molecular Weight:
502.31
Alias:
羟磷灰石,骨粉
Calcium hydroxyphosphate
Calcium phosphate tribasic
HAp
Hydroxylapatite
Durapatite
Product order:
Name |
Specifications |
Packing |
Price |
Delivery |
Hydroxylapatite |
BC |
500g |
RMB 1518 |
Consulting service |
Hydroxylapatite |
BC |
100g |
RMB 369.6 |
促销 |
Hydroxylapatite |
BC |
25g |
RMB 206.8 |
现货 |
Character:
几乎不溶于水.
羟基磷灰石的组成和晶体结构羟基磷灰石的理论组成为 Ca10(PO4)6(OH)2,Ca/P 为1.67,但由于受到制备过程的影响,其真正的组成是相当复杂的。 HA 晶体为六方晶系,属L6PC 对称型和P63/m空间群,其结构为六角柱体,与c 轴垂直的面是一个六边形,a、b 轴夹角120º;,其晶胞参数为a=9.43~9.38Å;,c=6.88~6.86Å;,z=2,单位晶胞含有10 个Ca2+、6 个PO43-和2 个OH-。HA 微晶表面具有几种可能的表面状态:(1)当OH 位于晶体表面时,OH 与2个Ca(Ⅱ)离子相连,当HA 在水溶液中时,这个表面OH 位置至少在某一瞬间空缺,由于2 个Ca(Ⅱ)离子带正电荷,形成了一个吸附位置,这个位置能吸附PO43-或大分子上的磷酸根基团或羧基基团。(2)当Ca 离子位于晶体的表面时,由于Ca(Ⅰ)与6 个带负电电荷的O 原子相连,当HA 在水溶液中,表面的Ca(Ⅰ)位置在某一瞬间空缺时,就在Ca(Ⅰ)位置形成较强的吸附位置,能吸附Sr3+、K+等阳离子及蛋白质分子的基团,而在 Ca(Ⅱ)位置则形成一个较弱的吸附位置。(3)PO43-位于晶体的表面时,H2O 通过氢键与PO43-离子结合。
Quality Standard:
平均粒径Every particle size ≤40nm
元素含量Assay( Ca10(PO4)6(OH)2) ≥96%
重金属Heavy metals (as Pb) ≤8ppm
砷As ≤1ppm
干燥失重Loss on drying 0.59%
灼烧失重Loss on ignition 2.59%
白度 96
PH值 7.41
盐酸不溶物Insolubles in HCl 0.02%
Storage:
用途 纯化蛋白质,从双链RNA中分离单链RNA,纯化DNA。
Related Products
- Bromoxylenol Blue
- Trimethyltetradecylammonium hydrogen sulfate
- Inosine-5'-monophosphate disodium salt octahydrate
- Aztreonam
- FASORACETAM
- (R)-2-Flurbiprofen
- Grape seed extract
- Z-Ala-OSu
- 5-Methoxyisatin
- 2′-Deoxyadenosine 5′-monophosphate
- Chlorodipiperidinocarbenium hexafluorophosphate
- Dichlorobis(2-(diphenylphosphino)ethylamine)ruthenium(II)
- Bleomycin
- CM-Cellulose
- Kaolin
- 1,2,3-Triazole
- Wortmannin
- Monodisperse fluorescent microspheres
- 2-(1-Oxy-pyridin-2-yl)-1,1,3,3-tetramethylisothiouronium tetrafluoroborate
- Formaldehyde-sodium bisulfite adduct
- Kieselguhr
- 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide
- Montmorillonite
- Thymosin beta 4 acetate
- Dichlorobis(tri-o-tolylphosphine)palladium(II)
- 1H,1H,2H-Perfluoro-1-hexene
- Ciprofloxacin lactate
- Baccatin III
- Agar tryptone soya
- CHLOROAURIC ACID HYDRATE
- Chloro(indenyl)bis(triphenylphosphine)ruthenium(II)
- Lercanidipine hydrochloride hemihydrate
- Span 20
- Prednisolone
- ETHYL 2-METHYL-3-PYRROLECARBOXYLATE
- 3-Amino-5-methylisoxazole
- Acetonitrile-d3
- Trietazine
- Adenosine 2′:3′-cyclic monophosphate sodium salt
- 4,4,4,4-(Porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)
- β-Nicotinamide adenine dinucleotide phosphate
- Coumachlor
- Di-μ-chlorotetraethylene dirhodium(I)
- Mitoguazone
- Methyldopa
- Carbon Nanotube
- (S)-(+)-1,1'-Binaphthyl-2,2'-diyl Bis(trifluoromethanesulfonate)
- Loratadine
- NA
- NA
- Valsartan
- Fmoc-Dap(Alloc)-OH
- Molecular sieves, 5 Å
- Sodium acetate-d3
- 4-Bromo-1,8-naphthalic anhydride
- Cefaclor
- 4-Bromophthalic anhydride
- D-Val-Leu-Arg p-nitroanilide
- Tungsten sulfide
- Potassium iodide starch paper
- Imidazole
- 2,6-DI-ME-4-(3-NITRO-PH)-1,4-2H-PYRIDINE-3,5-DICAR
- Triamcinolone acetonide
- VERMICULITE
- Quinidine Sulfate
- Biofermine
- Indene
- Cephradine
- 5-Phospho-D-ribose 1-diphosphate pentasodium salt
- 4-Acryloylmorpholine
- 2'-deoxythymidine-5'-triphosphate (dTTP), trisodium salt, dihydrate
- Tea polysaccharide
- Metformin hydrochloride
- 5-Chloroisatin
- FLAVIN ADENINE DINUCLEOTIDE
- 4,4′-Dimethoxybenzoin
- Specical indicator paper
- Cytidine 5′-triphosphate disodium salt
- Flibanserin
- Aminoferrocene